A5030324095- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- Cardiovascular Function and Risk Factors
- Cardiac, Anesthesia and Surgical Outcomes
- Coronary Interventions and Diagnostics
- Lipoproteins and Cardiovascular Health
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac pacing and defibrillation studies
- Cardiac Arrest and Resuscitation
- Cardiac electrophysiology and arrhythmias
- Cardiac Health and Mental Health
- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Pharmaceutical Economics and Policy
- Venous Thromboembolism Diagnosis and Management
- Clinical practice guidelines implementation
- Cardiac Valve Diseases and Treatments
- Blood Coagulation and Thrombosis Mechanisms
- Blood Pressure and Hypertension Studies
- Atherosclerosis and Cardiovascular Diseases
- Blood properties and coagulation
- Cardiomyopathy and Myosin Studies
Ospedale San Filippo Neri
2014-2024
ASL Roma
2018-2022
Assistance Publique – Hôpitaux de Paris
2017
Université de franche-comté
2017
University of Leeds
2017
Sorbonne Université
2017
Edinburgh Royal Infirmary
2017
IRCCS Humanitas Research Hospital
2017
Hôpital Rangueil
2017
Universidad Complutense de Madrid
2017
The ESC Guidelines represent the views of and were arrived at after careful consideration available evidence time they written.Health professionals are encouraged to take them fully into account when exercising their clinical judgement.The guidelines do not, however, override individual responsibility health make appropriate decisions in circumstances patients, consultation with that patient, where necessary patient's guardian or carer.It is also professional's verify rules regulations...
Guidelines and Expert Consensus Documents summarize evaluate all currently available evidence on a particular issue with the aim to assist physicians in selecting best management strategies for typical patient, suffering from given condition, taking into account impact outcome, as well risk–benefit ratio of diagnostic or therapeutic means. are no substitutes textbooks. The legal implications medical guidelines have been discussed previously. A great number issued recent years by European...
Guidelines for pre-operative cardiac risk assessment and perioperative management in non-cardiac surgery.
Recommendations for the use of cardiac troponin (cTn) measurement in acute care have recently been published.1 Subsequently, a high-sensitivity (hs) cTn T assay was introduced into routine clinical practice.2 This assay, as others, called highly sensitive, permits concentrations significant numbers apparently illness-free individuals. These assays can measure single digit range nanograms per litre (=picograms millilitre) and some research even allow detection 10% at 99th percentile URL...
The release of cardiomyocyte components, i.e. biomarkers, into the bloodstream in higher than usual quantities indicates an ongoing pathological process. Thus, detection elevated concentrations cardiac biomarkers blood is a sign injury which could be due to supply–demand imbalance, toxic effects, or haemodynamic stress. It up clinician determine most probable aetiology, proper therapeutic measures, and subsequent risk implied by For this reason, measurement always must applied relation...
Most of the guideline-recommended treatment strategies for patients with acute coronary syndromes have been tested in large randomised clinical trials. Still, a major challenge is represented by myocardial infarction admitted impending or established cardiogenic shock. Despite early revascularization mortality shock remains high and roughly half do not survive until hospital discharge 30-day follow-up. However, there only limited evidence-based scientific knowledge setting. Therefore,...
The prognostic value of natriuretic peptide elevations in patients with acute coronary syndromes (ACS) is still incompletely defined. We measured N-terminal pro-brain (NT-proBNP) on admission ACS and ECG evidence myocardial ischemia.The NT-proBNP was at a median time 3 hours after symptom onset 1756 patients. outcome measure death 30 days, which occurred 113 (6.4%). level 353 ng/L (107 to 1357 ng/L). Compared the lowest quartile, second, third, fourth quartiles had relative risk subsequent...
We investigated the association between 9 polymorphisms of genes encoding hemostasis factors and myocardial infarction in a large sample young patients chosen because they have less coronary atherosclerosis than older patients, thus their disease is more likely to be related genetic predisposition prothrombotic state.This nationwide case-control study involved 1210 who had survived first at an age <45 years underwent arteriography 125 care units healthy subjects matched for age, sex,...
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation (ending).
Evaluation of quality care is an integral part modern healthcare, and has become indispensable tool for health authorities, the public, press patients. However, measuring difficult, because it a multifactorial multidimensional concept that cannot be estimated solely on basis patients’ clinical outcomes. Thus, process through indicators (QIs) widely used practice in this context. Other professional societies have published QIs evaluation context acute myocardial infarction (AMI), but no such...
Abstract Aims Quality indicators (QIs) are tools to improve the delivery of evidence-base medicine. In 2017, European Society Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC) developed a set QIs acute myocardial infarction (AMI), which have been evaluated at national and international levels across different populations. However, an update these is needed in light accumulated experience changes supporting evidence. Methods results The ESC methodology QI development was used...
Reperfusion therapy in ST-segment elevation myocardial infarction (STEMI) is the most important component of treatment, as it strongly influences short- and long-term patient outcome. The main objective healthcare providers should be to achieve at least 75% reperfusion applied patients suffering from STEMI a timely manner, preferably within first 3 h after onset symptoms. Establishing networks regional national level, implying close collaboration between all actors involved therapy, namely...
The rate and type of reperfusion, as well time delays to reperfusion are directly associated with mortality established performance measures (PMs) in the treatment ST elevation myocardial infarction (STEMI). To date, little information exists about PMs for clinical practice Europe their temporal changes. Using Euro Heart Survey ACS-III data set (2 years inclusions between 2006 2008, 138 centres 21 countries), we selected patients STEMI eligible therapy. Recorded variables corresponded CARDS...
Detailed data on patients admitted for acute myocardial infarction (AMI) a European-wide basis are lacking. The Euro Heart Survey 2009 Snapshot was designed to assess characteristics, management, and hospital outcomes of AMI throughout European Society Cardiology (ESC) member countries in contemporary 'real-world' setting, using methodology improve the representativeness survey. Member ESC were invited participate 1-week survey all documented December 2009. Data baseline type AMI,...
Chest pain and acute dyspnoea are frequent causes of emergency medical services activation. The pre-hospital management these conditions is heterogeneous across different regions the world Europe, as a consequence variety absence specific practical guidelines. This position paper focuses on aspects treatment board transfer patients taken in charge by for chest suspected cardiac aetiology after initial assessment diagnostic work-up. objective to provide guidance, based evidence, where...
Two major changes in patient characteristics and management occurred recently that demand distinctive alterations the function of intensive cardiac care unit (ICCU). These include introduction an early invasive strategy for treatment acute coronary syndromes, enabling recuperation shorter need on one hand, while number older sicker patients requiring prolonged more complex is steadily increasing. A task force European Society Cardiology Working Group Acute Cardiac Care was set to give a...